Almost all patients to get higher subsidies in revised pallative care framework

The revisions in the subsidy framework will take effect in 2024.

The Ministry of Health (MOH) declared that it will enhance financing for pallative care and adjust claim limits for MediShield to improve affordability and accessibility to palliative care.

The subsidies to be improved are for inpatient palliative care, home palliative care, and day hospice care.

According to MOH, the new framework will allow all Singapore Citizens to get subsidies of at least 50%, regardless of their Per Capita Household Income (PCHI).

“Overall, almost all patients will benefit from higher subsidies, with increases of up to 55 percentage points. These changes will be implemented in the fourth quarter of 2024,” it said.

Under the framework, MediShield Life claim limits will grow for inpatient palliative care. The daily claim limits will be raised from $250 to $460 for general inpatient palliative care, and from $350 to $500 for specialised inpatient palliative care.

The MediSave, meanwhile, will remove $2,500 lifetime withdrawal limit for all home palliative care and day hospice patients who use their own MediSave. This will be effective in the first quarter of next year.

“The limit will remain for patients who tap on their family members’ MediSave, to preserve it for their own healthcare needs,” it added.

MOH will also improve drug and vaccine subsidies for long-term medical care services which include nursing home, home medical, and palliative care services.

It “will extend drug and vaccine subsidies of at least 50%, similar to what they would receive at public healthcare institutions, to all patients of MOH-funded providers of eligible long-term medical care services.”

“This will improve access to subsidised drugs and vaccines, especially for homebound patients,” said MOH.

Before, the subisidies are only deployed to long-term medical care patients from lower- to middle-income households.

The ministry will also extend drug and vaccine subsidies for patients utilising nursing home, home medical, home palliative care, and day hospice services with those at Specialist Outpatient Clinics. Such changes will take place in the fourth quarter of 2024.

Follow the link for more news on

Ministry of Health

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia